BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 12497646)

  • 1. Panic disorder patients at the time of air strikes.
    Starcevic V; Kolar D; Latas M; Bogojevic G; Kelin K
    Depress Anxiety; 2002; 16(4):152-6. PubMed ID: 12497646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Panic disorder subtypes: further clinical differences.
    Onur E; Alkin T; Tural U
    Depress Anxiety; 2007; 24(7):479-86. PubMed ID: 17106872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agoraphobia and panic. Prospective-longitudinal relations suggest a rethinking of diagnostic concepts.
    Wittchen HU; Nocon A; Beesdo K; Pine DS; Hofler M; Lieb R; Gloster AT
    Psychother Psychosom; 2008; 77(3):147-57. PubMed ID: 18277061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychopathology of panic attacks in panic disorder.
    Uhlenhuth EH; Leon AC; Matuzas W
    J Affect Disord; 2006 May; 92(1):55-62. PubMed ID: 16448702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A three-year follow-up study of patients with the respiratory subtype of panic disorder after treatment with clonazepam.
    Nardi AE; Valença AM; Nascimento I; Lopes FL; Mezzasalma MA; Freire RC; Veras AB; Zin WA; Versiani M
    Psychiatry Res; 2005 Nov; 137(1-2):61-70. PubMed ID: 16226812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nocturnal sleep panic and depression: relationship to subjective sleep in panic disorder.
    Singareddy R; Uhde TW
    J Affect Disord; 2009 Jan; 112(1-3):262-6. PubMed ID: 18558437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder.
    Pollack MH; Lepola U; Koponen H; Simon NM; Worthington JJ; Emilien G; Tzanis E; Salinas E; Whitaker T; Gao B
    Depress Anxiety; 2007; 24(1):1-14. PubMed ID: 16894619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The structure of lifetime panic-agoraphobic spectrum.
    Rucci P; Miniati M; Oppo A; Mula M; Calugi S; Frank E; Shear MK; Mauri M; Pini S; Cassano GB
    J Psychiatr Res; 2009 Jan; 43(4):366-79. PubMed ID: 18499126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of clonazepam on quality of life and work productivity in panic disorder.
    Jacobs RJ; Davidson JR; Gupta S; Meyerhoff AS
    Am J Manag Care; 1997 Aug; 3(8):1187-96. PubMed ID: 10170301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NAG level differences in panic disorder and agoraphobia.
    Garvey MJ; Noyes R
    J Anxiety Disord; 2005; 19(7):818-25. PubMed ID: 16076427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive style, alprazolam plasma levels, and treatment response in panic disorder.
    Uhlenhuth EH; Starcevic V; Qualls C; Antal EJ; Matuzas W; Javaid JI; Barnhill J
    Depress Anxiety; 2008; 25(8):E18-26. PubMed ID: 17960759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the clinical utility of agoraphobia in the context of panic disorder.
    Schmidt NB; Cromer KR
    Depress Anxiety; 2008; 25(2):158-66. PubMed ID: 17351905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid gamma-aminobutyric acid in patients with panic disorder.
    Rimón R; Lepola U; Jolkkonen J; Halonen T; Riekkinen P
    Biol Psychiatry; 1995 Dec; 38(11):737-41. PubMed ID: 8580226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of life in early phases of panic disorder: predictive factors.
    Carrera M; Herrán A; Ayuso-Mateos JL; Sierra-Biddle D; Ramírez ML; Ayestarán A; Hoyuela F; Rodríguez-Cabo B; Vázquez-Barquero JL
    J Affect Disord; 2006 Aug; 94(1-3):127-34. PubMed ID: 16762421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive factors in panic disorder, agoraphobic avoidance and agoraphobia.
    Berle D; Starcevic V; Hannan A; Milicevic D; Lamplugh C; Fenech P
    Behav Res Ther; 2008 Feb; 46(2):282-91. PubMed ID: 18191103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term experience with clonazepam in patients with a primary diagnosis of panic disorder.
    Worthington JJ; Pollack MH; Otto MW; McLean RY; Moroz G; Rosenbaum JF
    Psychopharmacol Bull; 1998; 34(2):199-205. PubMed ID: 9641001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anxiety sensitivity: a missing piece to the agoraphobia-without-panic puzzle.
    Hayward C; Wilson KA
    Behav Modif; 2007 Mar; 31(2):162-73. PubMed ID: 17307933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Panic disorder in Thailand: a report on the secondary data analysis.
    Udomratn P
    J Med Assoc Thai; 2000 Oct; 83(10):1158-66. PubMed ID: 11143481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Life events and social support in a 1-year preceding panic disorder.
    Batinić B; Trajković G; Duisin D; Nikolić-Balkoski G
    Psychiatr Danub; 2009 Mar; 21(1):33-40. PubMed ID: 19270619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-fearful vs. fearful panic attacks: a general population study from the National Comorbidity Survey.
    Chen J; Tsuchiya M; Kawakami N; Furukawa TA
    J Affect Disord; 2009 Jan; 112(1-3):273-8. PubMed ID: 18534684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.